Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for acute, chronic, and infected wounds; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company has licensed partnership with Becton, Dickinson & Company for urinary catheter bardex IC and lubrisil IC; Well Lead Medical for catheters and tubes; and Zimmer Biomet for orthopedic trauma implants. It operates in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
Frequently asked questions
What sector does Bactiguard Holding AB (publ) (BACTI-B) operate in?
Bactiguard Holding AB (publ) belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Bactiguard Holding AB (publ) (BACTI-B) current stock price?
As of the latest data, Bactiguard Holding AB (publ) stock price is SEK 15.50, with a previous close of SEK 15.55. Bactiguard Holding AB (publ) lost -SEK 0.05 in the last trading session, representing a -0.32% loss.
What is Bactiguard Holding AB (publ) (BACTI-B) current market capitalization?
Bactiguard Holding AB (publ) market cap is approximately 481.18 million.
What is Bactiguard Holding AB (publ) (BACTI-B) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.24, and the forward EPS is -SEK 0.47.
What is Bactiguard Holding AB (publ) (BACTI-B) EBITDA?
Bactiguard Holding AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.95 million.
Does Bactiguard Holding AB (publ) (BACTI-B) pay dividends?
No. Bactiguard Holding AB (publ) does not pay a dividend.
How did Bactiguard Holding AB (publ) (BACTI-B) perform in its most recent earnings report?
In the last report (June 30, 2026), Bactiguard Holding AB (publ) posted an EPS surprise of 6.48% and a revenue surprise of 3.85%.
What is Bactiguard Holding AB (publ) (BACTI-B) beta (volatility) score?
Bactiguard Holding AB (publ) has a beta of 0.406, indicating lower volatility than the overall market.
